News Contact VYLUMA ANNOUNCES POSITIVE RESULTS FROM SECOND STAGE OF PHASE III CHAMP STUDY OF NVK002 FOR THE TREATMENT OF MYOPIA IN CHILDREN Oct 11, 2023 | VylumaVyluma announced today positive top-line results from the second stage of its Phase III CHAMP (Childhood Atropine for Myopia Progression) clinical study of its lead compound… Visit Vyluma.com Visit Nevakarinjectables.com Regulatory
VYLUMA ANNOUNCES POSITIVE RESULTS FROM SECOND STAGE OF PHASE III CHAMP STUDY OF NVK002 FOR THE TREATMENT OF MYOPIA IN CHILDREN Oct 11, 2023 | VylumaVyluma announced today positive top-line results from the second stage of its Phase III CHAMP (Childhood Atropine for Myopia Progression) clinical study of its lead compound…